vimarsana.com

Latest Breaking News On - Assembly biosciences inc - Page 6 : vimarsana.com

Comparing Gilead Sciences (NASDAQ:GILD) & BioCardia (NASDAQ:BCDA)

Gilead Sciences (NASDAQ:GILD – Get Free Report) and BioCardia (NASDAQ:BCDA – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, dividends, analyst recommendations, institutional ownership and profitability. Insider and Institutional Ownership 82.3% of Gilead Sciences shares […]

Japan
California
United-states
Foster-city
Complera-eviplera
Pionyr-immunotherapeutics-inc
Japan-tobacco-inc
Tizona-therapeutics-inc
Gilead-sciences
Assembly-biosciences-inc
Merck-co-inc
Gilead-sciences-inc

Reviewing Big Cypress Acquisition (OTCMKTS:BCYP) and Gilead Sciences (NASDAQ:GILD)

Big Cypress Acquisition (OTCMKTS:BCYP – Get Free Report) and Gilead Sciences (NASDAQ:GILD – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations. Institutional & Insider Ownership 60.2% of Big […]

California
United-states
Florida
Foster-city
Japan
Miami-beach
Complera-eviplera
Janssen-sciences-ireland-unlimited-company
Tentarix-biotherapeutics-inc
Tango-therapeutics-inc
Pionyr-immunotherapeutics-inc
Big-cypress-acquisition-corp

Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®

Poster highlights potential of oral small molecule IFNAR agonist program to engage the IFNα pathway through a liver-focused approach to improve tolerability SOUTH SAN FRANCISCO, Calif., Nov. .

Boston
Massachusetts
United-states
William-delaney
Shannon-ryan
Alliance-management
Assembly-biosciences
Nasdaq
Securities-exchange
Exchange-commission
Assembly-biosciences-inc
Risk-factors-in-assembly-bio

Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 Assembly Biosciences, Inc. , a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced a.

Anuj-gaggar
Shannon-ryan
Assembly-bio
Nasdaq
Corporate-affairs
Alliance-management
Assembly-biosciences-inc
Assembly-biosciences
Chief-medical
Award-plan
Incentive-plan
Compensation-committee

Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

10.11.2023 - SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) - Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced a grant of inducement .

Anuj-gaggar
Assembly-bio
Nasdaq
Assembly-biosciences-inc
Chief-medical

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.